Inhalation Anthrax Treatment Approved

MONDAY, March 21, 2016 — Anthim (obiltoxaximab) has been approved by the U.S. Food and Drug Administration to treat inhalational anthrax, a rare disease stemming from infected animal products. Bacillus anthracis spores also pose a deadly…
Source: Topamax